Galson Steven K
SEC CIK 1495328 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dir | 27.8K | $120.5K | — | 6 | 2022-06-07 | 2026-06-11 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:30 | 2026-06-11 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | A - Grant | $0.00 | +15.3K | 27.8K | +122% | $0 |
| D | 2025-06-16 | 2025-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | A - Grant | $0.00 | +12.5K | 25.0K | +100% | $0 |
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | A - Grant | $0.00 | +6,820 | 36.4K | +23% | $0 |
| 2024-05-15 | 2024-05-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | P - Purchase | $5.49 | +21.9K | 51.6K | +74% | +$120.5K | |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | A - Grant | $0.00 | +16.7K | 29.6K | +130% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | Galson Steven K | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations